Immunohistochemistry
Research News and Information

Sunday, November 08, 2009

Establishment and characterization of a cancer cell line derived from an aggressive childhood liver tumor.

29 Nov 2009 BACKGROUND: Hepatoblastoma is a rare malignancy of childhood. The scarcity of adequate cell models has limited our understanding of this tumor. Here we describe and characterize a new human liver tumor cell line, Hep293TT, derived from an aggressive ... Read more...

VEGF expression as a prognostic marker in osteosarcoma.

29 Nov 2009 BACKGROUND: The vascular endothelial growth factor (VEGF) pathway is the key regulator of angiogenesis. In osteosarcoma baseline VEGF is of proven prognostic value but prognostic potential of post-NACT VEGF expression is largely unexplored. ... Read more...

Possible mechanisms involved in the discrepancy of hepatic and aortic endothelial nitric oxide synthases during the development of cirrhosis in rats.

25 Nov 2009 BACKGROUND/AIM: In cirrhosis, systemic nitric oxide (NO) overproduction and hepatic NO hypoproduction lead to arterial vasodilatation and portal hypertension. The mechanisms involved in these alterations in endothelial NO synthase (eNOS)-derived NO ... Read more...

Latest indexed articles for 'Immunohistochemistry'

These are the very latest articles for this heading:

• Establishment and characterization of a cancer cell line derived from an aggressive childhood liver tumor. 29 Nov 2009
• VEGF expression as a prognostic marker in osteosarcoma. 29 Nov 2009
• Possible mechanisms involved in the discrepancy of hepatic and aortic endothelial nitric oxide synthases during the development of cirrhosis in rats. 25 Nov 2009
• Diagnostic value of CD163 in cutaneous spindle cell lesions. 22 Nov 2009
• Androgen receptor as a potential sign of prostate cancer metastasis. 30 Oct 2009
• Genistein and resveratrol, alone and in combination, suppress prostate cancer in SV-40 tag rats. 30 Oct 2009
• In vitro propagation and characterization of neoplastic stem/progenitor-like cells from human prostate cancer tissue. 30 Oct 2009
• Comparison of ACINUS, caspase-3, and TUNEL as apoptotic markers in determination of tumor growth rates of clinically localized prostate cancer using image analysis. 30 Oct 2009
• Aurora B expression in post-puberal testicular germ cell tumours. 30 Oct 2009
• Assessment of "grading" with Ki-67 and c-kit immunohistochemical expressions may be a helpful tool in management of patients with flat epithelial atypia (FEA) and columnar cell lesions (CCLs) on core breast biopsy. 30 Oct 2009
• The human HIF (hypoxia-inducible factor)-3alpha gene is a HIF-1 target gene and may modulate hypoxic gene induction. 21 Oct 2009
• Altered nucleotide receptor expression in a murine model of cerebral malaria. 13 Oct 2009
• Comparison of the spatial distribution of seven types of neuroendocrine neurons in the rat paraventricular nucleus: toward a global 3D model. 8 Oct 2009
• Increased proximal bifurcation of CA1 pyramidal apical dendrites in sema3A mutant mice. 8 Oct 2009
• KLK6 and KLK13 predict tumor recurrence in epithelial ovarian carcinoma. 4 Oct 2009
• An innovative triple immunogold labeling method to investigate the hemopoietic stem cell niche in situ. 29 Sep 2009
• A 76-year-old man with cognitive and neurological symptoms. 29 Sep 2009
• Robust detection of EGFR copy number changes and EGFR variant III: technical aspects and relevance for glioma diagnostics. 29 Sep 2009
• Astrocytes are more resistant to focal cerebral ischemia than neurons and die by a delayed necrosis. 29 Sep 2009
• Alpha-parvin controls vascular mural cell recruitment to vessel wall by regulating RhoA/ROCK signalling. 29 Sep 2009

See a longer list of these articles.

Technical information about 'Immunohistochemistry'

Definition: Histochemical localization of immunoreactive substances using labeled antibodies as reagents.

Descriptor UI: D007150

Alternative terms: Immunohistochemistry; Immunolabeling Techniques; Immunolabeling Technique; Technique, Immunolabeling; Techniques, Immunolabeling; Immunolabeling Technics; Immunolabeling Technic; Technic, Immunolabeling; Technics, Immunolabeling; Immunogold Techniques; Immunogold Technique; Technique, Immunogold; Techniques, Immunogold; Immunogold Technics; Immunogold Technic; Technic, Immunogold; Technics, Immunogold; Immunohistocytochemistry; Immunogold-Silver Techniques; Immunogold Silver Techniques; Immunogold-Silver Technique; Technique, Immunogold-Silver; Techniques, Immunogold-Silver; Immunogold-Silver Technics; Immunogold Silver Technics; Immunogold-Silver Technic; Technic, Immunogold-Silver; Technics, Immunogold-Silver; Immunocytochemistry;

Allowable Qualifiers: history; instrumentation; methods; standards; trends; utilization; veterinary; statistics & numerical data; ethics; classification; economics;

Tree Number: E01.450.495.435; E05.200.500.607.512; E05.200.750.551.512; E05.478.594.430; H01.158.100.656.234.512; H01.158.201.344.512; H01.158.201.486.512; H01.181.122.573.512; H01.181.122.605.512;

History Note: 88

Technical Notes: GEN; avoid as coord; SPEC qualif when IM; no qualif when NIM; immunohistochem of disease is disease /diag or /metab